In the present study we describe the complete cytochrome P450 complement, the "CYPome," of Streptomyces coelicolor A3(2). Eighteen cytochromes P450 (CYP) are described, in contrast to the absence of CYPs in Escherichia coli, and the twenty observed in Mycobacterium tuberculosis. Here we confirm protein identity as cytochromes P450 by heterologous expression in E. coli and measurement of reduced carbon monoxide difference spectra. We also report on their arrangement in the linear chromosome and relatedness to other CYPs in the superfamily. The future development of manipulation of antibiotic pathways and the use of streptomycetes in bioremediation and biotransformations will involve many of the new CYP forms identified here.
Cytochrome P450 (CYP) 1 -dependent monooxygenases are a superfamily of heme-containing enzymes that are involved in a wide array of NADPH-/NADH-and O 2 -dependent reactions (1, 2) . Extensive studies in animals have established their role in metabolism of xenobiotic drugs and toxic chemicals as well as endogenous compounds such as sterols, fatty acids, and prostaglandins (3) (4) (5) . Recently, the completion of fully sequenced genomes of prokaryotes and eukaryotes has revealed the extraordinary biodiversity of this superfamily. To date, as judged from sequence motifs alone, there are ϳ57 CYP genes in humans, ϳ90 in Drosophila melanogaster, ϳ80 in Caenorhabditis elegans, and ϳ275 in Arabidopsis thaliana (6) . Additionally, CYP genes are also found in many microorganisms: three in the bakers' yeast Saccharomyces cerevisiae, ϳ150 in the white rot fungus Phanerochaete chrysosporium, and 20 in Mycobacterium tuberculosis, but Escherichia coli carries none (7) . CYP proteins are extremely diverse in amino acid sequence with CYPs having less than 40% amino acid identity being placed in different families (8) . Common features, such as the cysteine ligand to the prosthetic heme and its flanking conserved residues, allow most CYP sequences to be recognized (9) . For catalytic activity, CYPs must be associated with their electron donor partner proteins, either NADPH cytochrome P450 reductase for microsomal eukaryotic CYPs or ferredoxin/ferredoxin reductase complex for prokaryotic and mitochondrial CYPs (for review see Ref. 10 ).
Streptomycetes produce a vast array of antibiotics applied in human and veterinary medicine and agriculture, as well as anti-parasitic agents, herbicides, and pharmacologically active metabolites (e.g. immunosuppressants). Streptomycetes also catalyze numerous transformations of xenobiotics of industrial and environmental importance (11, 12) . These oxidative transformations have been observed with alkaloids (13), coumarins (14) , retinoids (15) , and other complex xenobiotics (16) . Industrial application has been exploited in the synthesis of pravastatin utilizing a streptomycete biotransformation step (17) as well as in 16-hydroxylation of steroids (18) and in the preparation of drug metabolites for toxicological evaluation (19) .
Streptomyces coelicolor A3 (2) is the most studied member of the genus in molecular genetic investigations and has become a paradigm for the actinomycetes. In 1997, the Sanger Centre initiated a program to sequence the 8-Mb genome of S. coelicolor A3(2) (www.sanger.ac.uk/Projects/S_coelicolor/). The project has been carried out at the Sanger Centre at Hinxton, Cambridge, UK, was funded by the Biotechnology and Biological Science Research Council and the Beowulf Genomics initiative of the Wellcome Trust, and was completed in July 2001. Eighteen CYP sequences from S. coelicolor A3(2) have been revealed from the genome-sequencing project, but their endogenous roles and contribution to S. coelicolor A3(2) biology remain unknown. The present paper describes the biochemical verification of the complete cytochrome P450 complement (the so-called CYPome) of S. coelicolor A3(2) and discusses the potential function. Results are described in consideration of the evolution of the cytochrome P450 superfamily as a whole, particularly among the actinomycetes.
MATERIALS AND METHODS

DNA Manipulations-
The open reading frames (ORFs) of the putative cytochrome P450 enzymes present in the S. coelicolor A3(2) genome were revealed through analysis of the presence of CYP heme-binding motifs in the genomic information as it was deposited. Eighteen CYP ORFs were identified, and the corresponding DNA sequences were isolated by PCR and cloned into the E. coli expression vector pET17b (Novagen) using the NdeI and HindIII sites. Forward and reverse primers to isolate each CYP are described in Table I . In each PCR product an NdeI site encoding ATG was incorporated defining the 5Ј of the open reading frame. Also the stop triplet was removed and triplets encoding four histidine were inserted for subsequent protein purification studies. These were followed by a new stop signal, and beyond the reading frame a HindIII site was included to facilitate cloning into pET17b. In four cases the predicted initiating codon was not ATG, CYP155A1, CYP157A1, CYP157B1, and CYP157C1, and in these cases the initiating triplet of the gene construct for expression was replaced by ATG within an NdeI site. The expression vector for each individual CYP was transformed separately into competent HMS174 (Novagen) cells of E. coli prior to heterologous expression and purification according to Bellamine et al. (20) .
Bioinformatic Analysis-Data were collected at various addresses indicated in the table legends. CYPs were detected in homology searches (BLAST and Pfam) using the conserved heme-binding domain signature and were identified also at ScoDB using a similar approach.
Other features conserved in CYPs were identified by amino acid alignment and included visual assessment with reference to the known features of the superfamily. Phylogenetic trees were calculated using ClustalX and TreeView. The names of genes are given in their S. coelicolor A3(2) order in the cosmids sequenced and available at ScoDB (jic-bioinfo.bbsrc.ac.uk/streptomyces/). CYP family and subfamily assignments were made by Dr. David Nelson according to the P450 nomenclature (8, 9) . In this, Ͼ40% identity places a CYP in the same family (unless homologues with lower identity are demonstrated to be functionally equivalent) and Ͼ55% places it in the same subfamily (e.g.
CYP154A1, CYP154C1, etc).
General Methods-Sodium dithionite-reduced carbon monoxide difference spectra for quantification of cytochrome P450 contents were measured and calculated according to the method described by Omura and Sato (21) . Similar spectra obtained using ferredoxin and ferredoxin reductase proteins to reduce CYP used the electron donor system method described previously for CYP51 from M. tuberculosis (20) . For this system proteins were first purified using Ni 2ϩ -NTA chromatography. Protein quantification was performed by using the Bicinchoninic acid assay. Unless otherwise stated all chemicals were supplied by Sigma.
RESULTS AND DISCUSSION
The cytochrome P450 superfamily has members present in all kingdoms of life, although they can be highly diverse in activity and function. Their role in secondary metabolism is well established as is likely reflected in the ϳ275 CYPs observed in A. thaliana. The genome of S. coelicolor A3(2) is of applied interest as the model for the category of microbial organisms producing the highest number of medicinal natural products in use today. The primary amino acid sequence of CYPs is highly variable, but secondary and tertiary structures are generally conserved as revealed by the known structures.
In S. coelicolor A3(2) 18 CYPs were detected through continued analysis of the progressing genome-sequencing project, which was recently completed. Detection of probable CYPs within a genome is facilitated by the presence of consensus sequences within the primary structure that are known to be present in all CYPs. Primary sequence motifs are important to the secondary and tertiary structure with three amino acids conserved throughout the superfamily. These are EXXR in the K-helix and the cysteine residue, which forms a fifth axial ligand to the heme iron. Two other very highly conserved residues in CYPs are two glycine residues, four amino acids upstream of the conserved cysteine, and a threonine residue in the I-helix, which is proposed to be involved in oxygen activation. The sequences near these highly conserved amino acids are sometimes conserved within CYP gene families, but variability can also be accommodated. Table I shows the motifs selected as most closely corresponding to these conserved CYP expectations; the genes were detected using the consensus heme-binding domain and known variants to do a protein motif search in the S. coelicolor A3(2) chromosomal sequence data base (www.sanger.ac.uk/Projects/ S_coelicolor/). Some of the CYP sequences contain variant sequences, particularly in the EXXR domain in the K-helix, and further investigation of the basis and relevance of these alterations is underway experimentally. All of these CYPs were subject to heterologous expression, and this confirmed their identity as cytochromes P450. All CYPs were soluble, locating to the cytosolic fraction on expression in E. coli with reduced carbon monoxide difference spectra of soluble protein giving maxima located around 448 nm (Table II) . Despite the high G and C content of S. coelicolor A3(2) genome expression levels were often extremely high, but five proved difficult to express, often with low and intermittent yield. CYP51 and CYP107U1 sometimes gave variable spectral maxima toward 440 nm in different preparations. Four genes had valine triplets at the 5Ј of the putative open reading frame, and these were replaced with ATG in the engineered genes used for expression in E. coli. The identification of heterologous expression of these CYPs supports the correct identification of the initiation sites. The importance of rare E. coli codons in the S. coelicolor A3(2) CYPs may contribute to low level expression, but these codons were also observed in highly expressing CYPs such as CYP105D5. Examples of the reduced carbon monoxide difference spectra of highly expressed and lowly expressed CYP forms are presented in Fig. 1 . Table III gives the potential redox partners for CYPs detectable in the genome. Interestingly, a ferredoxin (3SCF60.05c) is probably associated in an operon with CYP105D5 whose most well known homologue is CYP105D1 from Streptomyces griseus (69.5% amino acid identity) (22) and has even stronger identity with S. lividans CYP105D4 (Ͼ90% amino acid identity). Three ferredoxin reductase homologues were identified in the genome and were evaluated for their role in support of the CYP proteins. The production and purification of these putative redox partners and the ferredoxin product of 3SCF60.05c was undertaken using recombinant methods as for CYPs. Reduction of CYP was confirmed in the case of CYP105D5 and CYP105N1 as shown by the generation of carbon monoxide-reduced difference spectra measured after 10 min in the presence of cofactor and compared with that obtained using sodium dithionite reduction. Using SC4B10.18c protein and NADH, we observed 90 and 70% of the reduction observed using dithionite for CYP105D5 and CYP105N1, respectively. Using SCF15.02 protein and NADPH, 80% reduction of CYP105D5 and 16% reduction of CYP105N1 was observed while for SCF15.02 protein and NADH only Ͻ10% reduction of CYP105D5 and 20% reduction of CYP105N1 occurred. This showed that SC7A8.08c was the least effective ferredoxin reductase partner. In the complete evaluation of redox partners for S. coelicolor CYPs the knowledge of endogenous substrate is a prerequisite for identification of reduction partners and kinetics for this matrix of combinations. Natural electron transfer from reductase in the CYP catalytic cycle occurs to substrate-bound enzyme.
A phylogenetic tree was constructed of the S. coelicolor A3(2) CYPome in conjunction with the CYPome of M. tuberculosis, another closely related actinomycete (Fig. 2) . The M. tuberculosis genome contains 20 CYPs in ϳ3800 predicted ORFs in contrast to the 18 CYPs in ϳ7500 predicted ORFs of S. coelicolor A3(2). One clan of five CYPs consists entirely of S. coelicolor A3(2) proteins; other groups are mixed or predominantly from one genome or the other. No striking level of conserved homology across the CYPome was observed, which probably reflects the divergence of these bacterial species into their different niches. The major classes of the actinomycetes have been estimated to have originated in the last 500 million years (23) . Possibly the environmental soil organism, S. coelicolor A3(2), has need of detoxifying, and secondary metabolism resulting in the evolution of a distinct CYPome from M. tuberculosis where the CYPome may also be closely involved in synthesis of its complex lipid wall. Table IV shows information on each CYP concerning the number of amino acids and homology to other CYPs. Some show moderate to high level homologies to CYPs with known activities, others less so. One of the low-level homologies is a CYP51-like protein (SC 7E4.20) . CYP51 is the only CYP found in bacteria, plants, fungi, protists, and animals. In bacteria it was first shown in M. tuberculosis (20) . Phylogenetically, it is located in a cluster of CYPs associated with likely lipid metabolism roles including sterol 14-demethylase of M. tuberculosis (Rv0764c) and SC F43.12 (CYP102B1). CYP102B1 is the longest bacterial CYP encountered so far at 527 amino acids.
CYP105D5 and surrounding genes had the closest homology to the S. lividans AUD4 gene cluster (24) . A S. griseus protein associated with the metabolism of a vast array of xenobiotics is also encoded by a homologue with high identity (16, 25) . As in both species the CYP105D5 is adjacent to a ferredoxin but not a ferredoxin reductase. This CYP is particularly interesting from the viewpoint of a detoxifying role in the soil environment where the bacteria may be exposed to toxic secondary metabolites from live organisms and decaying organic material. Furthermore, CYP105 proteins are important in biotransformations and bioremediation, including their use in manipulating plant herbicide tolerance (16, 26) . CYP107U1, CYP107P1, and CYP107T1 are three CYP107 members in the genome. The first has homology to CYP113 as well as the latter to cytochrome P450 EryF, a known enzyme of antibiotic production (27) . These proteins may also participate in secondary metabolism.
CYP155A1 has low-level homology to other CYPs. CYP156A1 and CYP154A1 are located adjacent on the same strand with only a 12-bp separation. This points to a related function with CYP159A1 and CYP157B1 are also adjacent genes but on opposite strands. Their homologies indicate different functions for each. CYP157C1 has homology to known CYP proteins that are orphans with little clue as to function. CYP158A2 has 81.4% identity with a CYP from Streptomyces avermitilis (29) , and also the genetic locus is similar on the S. avermitilis chromosome. That includes the adjacent polyketide synthase suggesting a role in secondary metabolism. CYP158A1 also has 58.7% identity with this S. avermitilis CYP. CYP105N1 is again similar to other CYPs involved in xenobiotic metabolism but is located in a likely operon of secondary metabolism including probable non-ribosomal peptide synthases, a probable thioesterase, and probable ABC transporter. others appearing from almost every known genome sequence. The vast majority of these are of unknown function, and assigning function is the challenge for this and many other projects. However, the information on the S. coelicolor A3(2) CYPome has allowed progress to structural biology studies and proteomics, and analyzing mutant metabolomes represents the best way forward toward identifying function. 
